Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Rapamycin in anemia

Sep. 13, 1996

Vitamin D3 derivatives for osteoporosis

Sep. 13, 1996

New estrogen agonists and antagonists

Sep. 13, 1996

Novel treatment for bone loss

Sep. 13, 1996

Antitumor agents from Samjin

Sep. 13, 1996

IL-2 receptor-binding polypeptide described by Boehringer Ingelheim

Sep. 13, 1996

The Liposome Company prepares and formulates new taxanes

Sep. 13, 1996

Improved camptothecin derivatives

Sep. 13, 1996

New consensus interferon from Amgen

Sep. 13, 1996

Inhibitors of cytokine production reported by SmithKline Beecham

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...